It means there is a wide range of possible dose options from lower efficacy (i.e. 150 mg/m2 ) which animal studies indicated measurable increases of p2, to highest tolerated dose which is now 450 mg/m2 and might be peak p21. Lower dose options are especially important for multiple weekly administration as well as combination therapies with highly toxic drugs and a wide bandwidth allows that.